These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 10051123)
1. Proliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulin. Smith AJ; McKernan RM Br J Pharmacol; 1999 Jan; 126(1):79-86. PubMed ID: 10051123 [TBL] [Abstract][Full Text] [Related]
2. Characterisation of CCKB receptors on GH3 pituitary cells: receptor activation is linked to Ca2+ mobilisation. Smith AJ; Patel S; Freedman SB Eur J Pharmacol; 1994 Apr; 267(2):215-23. PubMed ID: 8050481 [TBL] [Abstract][Full Text] [Related]
3. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion. Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253 [TBL] [Abstract][Full Text] [Related]
4. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells. Staley J; Jensen RT; Moody TW Peptides; 1990; 11(5):1033-6. PubMed ID: 2178246 [TBL] [Abstract][Full Text] [Related]
5. Gastrin and CCK activate phospholipase C and stimulate pepsinogen release by interacting with two distinct receptors. Qian JM; Rowley WH; Jensen RT Am J Physiol; 1993 Apr; 264(4 Pt 1):G718-27. PubMed ID: 8476056 [TBL] [Abstract][Full Text] [Related]
6. CCK-B receptor-mediated stimulation of polyphosphoinositide turnover in GH3 pituitary cells in response to cholecystokinin and pentagastrin. Smith AJ; Freedman SB Life Sci; 1996; 58(11):883-95. PubMed ID: 8786694 [TBL] [Abstract][Full Text] [Related]
7. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33). Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685 [TBL] [Abstract][Full Text] [Related]
8. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide. Boyle SJ; Tang KW; Woodruff GN; McKnight AT Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944 [TBL] [Abstract][Full Text] [Related]
9. The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines. Ohlsson B; Fredäng N; Axelson J Scand J Gastroenterol; 1999 Dec; 34(12):1224-9. PubMed ID: 10636070 [TBL] [Abstract][Full Text] [Related]
10. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts. Absence of detectable cholecystokinin (CCK)-A and CCK-B receptors. Singh P; Owlia A; Espeijo R; Dai B J Biol Chem; 1995 Apr; 270(15):8429-38. PubMed ID: 7721737 [TBL] [Abstract][Full Text] [Related]
11. Paracrine stimulation of cell growth by cholecystokinin/gastrin through cholecystokinin-B receptor on GH3 cells in vitro. Xu Y; Kaji H; Okimura Y; Matsui T; Abe H; Chihara K Neuroendocrinology; 1996 Oct; 64(4):280-5. PubMed ID: 8895857 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of both CCK-A and CCK-B receptors activates MAP kinases in AR42J and receptor-transfected CHO cells. Dabrowski A; Detjen KM; Logsdon CD; Williams JA Digestion; 1997; 58(4):361-7. PubMed ID: 9324163 [TBL] [Abstract][Full Text] [Related]
13. Characterization of CCKA receptor mediated pepsinogen secretion in porcine chief cells. Meyer G; Beinborn M; Sewing KF Pharmacology; 1996 Jul; 53(1):48-59. PubMed ID: 8875601 [TBL] [Abstract][Full Text] [Related]